Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
NRG Oncology
University of Kentucky
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Taiwan University Hospital
Alliance for Clinical Trials in Oncology
Dana-Farber Cancer Institute
Emory University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dana-Farber Cancer Institute
NRG Oncology
University of California, Davis
University of Iowa
University of Michigan Rogel Cancer Center
Royal Marsden NHS Foundation Trust
University of California, San Francisco
Emory University
RTOG Foundation, Inc.
Thomas Jefferson University
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
Washington University School of Medicine
University of Nebraska
St. Jude Children's Research Hospital
Stanford University
Medical College of Wisconsin
University of Colorado, Denver
M.D. Anderson Cancer Center
Washington University School of Medicine
NRG Oncology
H. Lee Moffitt Cancer Center and Research Institute
St. Jude Children's Research Hospital
Massachusetts General Hospital
Peter MacCallum Cancer Centre, Australia
Institut Bergonié
Universität des Saarlandes
Emory University
Mayo Clinic
Dana-Farber Cancer Institute
Thomas Jefferson University
Thomas Jefferson University
University of Michigan Rogel Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Thomas Jefferson University
Thomas Jefferson University
Thomas Jefferson University